-
1441
Principles of effective out-patient diagnostics of diffuse liver diseases
Published 2014-11-01“…In the case of abnormal liver tests preliminary diagnosis was determined according to certain algorithm and these patients were recruited for further investigation and specifications of diagnosis in department of hepatology, University clinical hospital N 2, State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university». …”
Get full text
Article -
1442
-
1443
-
1444
The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors
Published 2020-01-01Get full text
Article -
1445
-
1446
Provocative tests of anal sphincter function correlate with symptoms and subtypes of faecal incontinence
Published 2025-02-01Get full text
Article -
1447
Autoimmune Hepatitis in Children: The Current State of the Problem
Published 2018-11-01“…., those formulated by the main group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) members.Conclusion. …”
Get full text
Article -
1448
-
1449
-
1450
Shear Wave Elastography versus Strain Elastography in Diagnosing Parathyroid Adenomas
Published 2020-01-01Get full text
Article -
1451
Management of Irritable Bowel Syndrome: Novel Approaches to the Pharmacology of Gut Motility
Published 1999-01-01Get full text
Article -
1452
Increased Expression of Visfatin in Monocytes and Macrophages in Male Acute Myocardial Infarction Patients
Published 2012-01-01Get full text
Article -
1453
-
1454
-
1455
Correlations among PPAR𝜸, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer
Published 2012-01-01Get full text
Article -
1456
-
1457
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
Published 2024-08-01“…The Russian Scientific Liver Society selected a panel of experts in the field of therapeutic and surgical hepatology, hematology, transfusion medicine to make reasoned statements and recommendations on the issue of treatment of thrombocytopenia before elective surgery / invasive procedures in patients with liver cirrhosis.Results. …”
Get full text
Article -
1458
Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis
Published 2021-01-01Get full text
Article -
1459
Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Published 2025-02-01Get full text
Article -
1460
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article